Maynard Um
-
-
-
-
-
-
-
Akari Therapeutics changes ADS ratio to maintain Nasdaq listing
-
-
-
-
-
-
-
Akari Therapeutics files two patents for cancer drug platform
-
-
-
-
-
-
-
Akari Therapeutcis (AKTX) Granted Patent Protection Across India
-
-
-
-
-
-
-
Akari Therapeutcis (AKTX) Regains Nasdaq Compliance
-
-
423,222 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

